Table 5 Interaction between placebo and yokukansan groups on change after 12 weeks of smoking cessation intervention
Placebo group (n = 53) | Yokukansan group (n = 55) | interaction [baseline and 12-week]x [Placebo and Yokukansan] | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Mean difference | 95% Confident interval | d a | Mean difference | 95% Confident interval | d a | P value b | pη2 c | |||
BMI (kg/m2) | 0.45 | 0.12, | 0.17 | 0.382 | 0.52 | 0.29, | 0.76 | 0.616 | .705 | 0.002 |
SBP (mm Hg) | -0.12 | -5.92, | 5.68 | 0.006 | 5.87 | 1.07, | 10.7 | 0.337 | .112 | 0.026 |
DBP (mm Hg) | -1.41 | -5.17, | 2.35 | 0.106 | 1.70 | -.165, | 5.04 | 0.140 | .217 | 0.012 |
CO (ppm) | -14.1 | -17.2, | -11.0 | 1.369 | -13.5 | -16.9, | -10.0 | 1.131 | .781 | 0.014 |
SDS test score | -3.51 | -5.83, | -1.19 | 0.417 | -4.56 | -6.81, | -2.30 | 0.551 | .518 | 0.000 |
POMS score | ||||||||||
Tension-Anxiety(T-A) | -1.59 | -2.48, | -0.71 | 0.518 | -1.60 | -2.85, | -0.35 | 0.363 | .992 | 0.001 |
Depression-Dejection(D) | -0.12 | -0.95, | 0.71 | 0.042 | -1.88 | -3.11, | -0.65 | 0.436 | .019 | 0.024 |
Anger-Hostility (A-H) | -0.08 | -1.26, | 1.10 | 0.020 | -1.26 | -2.59, | 0.07 | 0.270 | .186 | 0.001 |
Vitality(V) | 1.16 | -0.02, | 2.34 | 0.283 | 1.14 | -0.32, | 2.60 | 0.222 | .980 | 0.000 |
Fatigue(F) | -0.49 | -1.79, | 0.81 | 0.108 | -2.14 | -3.43, | -0.85 | 0.472 | .073 | 0.006 |
Confusion(C) | -0.57 | -1.40, | 0.26 | 0.197 | -1.00 | -1.80, | -0.20 | 0.356 | .457 | 0.002 |